By clicking SUBMIT, you are certifying that you are 18 years or older and are signing another individual up to receive information from AstraZeneca about programs and services related to LUMOXITI.
We protect your information.
AstraZeneca respects your personal health information. By completing this registration, you are confirming that you are a US Resident and are at least 18 years old. The information you provide may be used to send you health-related materials and to develop products, services, and programs. AstraZeneca, or third parties working on our behalf, will not sell or rent personal health information. If in the future you no longer want to receive health-related materials, call 1-800-236-9933. Please visit www.azprivacynotice.com to review our Privacy Notice.
Your healthcare provider will check your weight and blood pressure before you receive each dose of LUMOXITI and as needed during treatment.
Your healthcare provider will do blood tests to check your blood cells and kidneys before you receive each dose of LUMOXITI and during treatment as recommended by your healthcare provider.
If you develop any of these symptoms of CLS or HUS, your healthcare provider may monitor you in the hospital.
Your healthcare provider will check you for these problems during your treatment with LUMOXITI. Your healthcare provider may delay or completely stop treatment with LUMOXITI if you have severe side effects.
Your healthcare provider may give you medicines to take before and after each LUMOXITI infusion.
Your healthcare provider will do blood tests to check your electrolytes before you receive each dose of LUMOXITI and during treatment as recommended by your healthcare provider.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
These are not all the possible side effects of LUMOXITI.
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
LUMOXITI is a prescription medicine used to treat adults with hairy cell leukemia (HCL)
It is not known if LUMOXITI is safe and effective in children.
You may report side effects related to AstraZeneca products by clicking here.